tiprankstipranks
Advertisement
Advertisement
Tango Therapeutics 18.2M share Secondary priced at $30.00
PremiumThe FlyTango Therapeutics 18.2M share Secondary priced at $30.00
22d ago
Tango Therapeutics price target raised to $66 from $27 at H.C. Wainwright
Premium
The Fly
Tango Therapeutics price target raised to $66 from $27 at H.C. Wainwright
23d ago
Tango Therapeutics price target raised to $42 from $30 at Canaccord
Premium
The Fly
Tango Therapeutics price target raised to $42 from $30 at Canaccord
23d ago
Midday Fly By: Nvidia partners with SK Hynix, Campbell’s reports Q3 beat
PremiumThe FlyMidday Fly By: Nvidia partners with SK Hynix, Campbell’s reports Q3 beat
24d ago
Tango Therapeutics rises 45.5%
Premium
The Fly
Tango Therapeutics rises 45.5%
24d ago
Tango Therapeutics upgraded at Wolfe after ‘impressive’ vopimetsotat combo data
Premium
The Fly
Tango Therapeutics upgraded at Wolfe after ‘impressive’ vopimetsotat combo data
24d ago
Tango Therapeutics Highlights Promising Vopimetostat Combination Data
PremiumCompany AnnouncementsTango Therapeutics Highlights Promising Vopimetostat Combination Data
24d ago
Tango Therapeutics announces data from study of vopimetostat, daraxonrasib
Premium
The Fly
Tango Therapeutics announces data from study of vopimetostat, daraxonrasib
24d ago
Tango Therapeutics Holds 2026 Virtual Annual Stockholder Meeting
Premium
Company Announcements
Tango Therapeutics Holds 2026 Virtual Annual Stockholder Meeting
27d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100